Isolation of circulating lung tumour cells using a non-EpCAM-based capture method

  • Cecilia Bozzetti
  • Andrea Cavazzoni
  • Cecilia Carubbi
  • Prisco Mirandola
  • Marcello Tiseo
  • Pier Giorgio Petronini
  • Andrea Ardizzoni
Lettera

Isolamento di cellule circolanti di tumore polmonare mediante separazione immunomagnetica

References

  1. 1.
    Hou JM, Krebs MG, Lancashire L et al (2012) Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 30:525–532PubMedCrossRefGoogle Scholar
  2. 2.
    Krebs MG, Sloane R, Priest L et al (2011) Evaluation and prognostic significance of circulating tumor cells in patients with nonsmall-cell lung cancer. J Clin Oncol 29:1556–1563PubMedCrossRefGoogle Scholar
  3. 3.
    Hou JM, Greystoke A, Lancashire L et al (2009) Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol 175:808–816PubMedCrossRefGoogle Scholar
  4. 4.
    Maheswaran S, Sequist LV, Nagrath S et al (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359:366–377PubMedCrossRefGoogle Scholar
  5. 5.
    Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428PubMedCrossRefGoogle Scholar
  6. 6.
    Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelialmesenchymal transitions in development and disease. Cell 139:871–890PubMedCrossRefGoogle Scholar
  7. 7.
    Kasimir-Bauer S, Hoffmann O, Wallwiener D et al (2012) Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res 14:R15PubMedCrossRefGoogle Scholar
  8. 8.
    Bunn PA Jr, Helfrich B, Soriano AF et al (2001) Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. Clin Cancer Res 7:3239–3250PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Cecilia Bozzetti
    • 1
    • 4
  • Andrea Cavazzoni
    • 2
  • Cecilia Carubbi
    • 3
  • Prisco Mirandola
    • 3
  • Marcello Tiseo
    • 1
  • Pier Giorgio Petronini
    • 2
  • Andrea Ardizzoni
    • 1
  1. 1.Medical Oncology UnitUniversity Hospital of ParmaParmaItaly
  2. 2.Department of Experimental Medicine, Unit of Experimental OncologyUniversity of ParmaParmaItaly
  3. 3.Department of Anatomy, Pharmacology and Forensic MedicineUniversity of ParmaParmaItaly
  4. 4.Medical Oncology UnitUniversity HospitalParmaItaly

Personalised recommendations